|
1
|
Huang DQ, Terrault NA, Tacke F, Gluud LL,
Arrese M, Bugianesi E and Loomba R: Global epidemiology of
cirrhosis-aetiology, trends and predictions. Nat Rev Gastroenterol
Hepatol. 20:388–398. 2023.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Hsu YC, Huang DQ and Nguyen MH: Global
burden of hepatitis B virus: Current status, missed opportunities
and a call for action. Nat Rev Gastroenterol Hepatol. 20:524–537.
2023.PubMed/NCBI View Article : Google Scholar
|
|
3
|
World Health Organization. Hepatitis B.
Fact sheet. Geneva, 2025. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-b.
|
|
4
|
Suh YG, Kim JK, Byun JS, Yi HS, Lee YS,
Eun HS, Kim SY, Han KH, Lee KS, Duester G, et al: CD11b(+) Gr1(+)
bone marrow cells ameliorate liver fibrosis by producing
interleukin-10 in mice. Hepatology. 56:1902–1912. 2012.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Kornek M, Popov Y, Libermann TA, Afdhal NH
and Schuppan D: Human T cell microparticles circulate in blood of
hepatitis patients and induce fibrolytic activation of hepatic
stellate cells. Hepatology. 53:230–242. 2011.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Hammerich L and Tacke F: Hepatic
inflammatory responses in liver fibrosis. Nat Rev Gastroenterol
Hepatol. 20:633–646. 2023.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Usami M, Miyoshi M and Yamashita H: Gut
microbiota and host metabolism in liver cirrhosis. World J
Gastroenterol. 21:11597–11608. 2015.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Levy M, Blacher E and Elinav E:
Microbiome, metabolites and host immunity. Curr Opin Microbiol.
35:8–15. 2017.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Luedde T and Schwabe RF: NF-kappaB in the
liver-linking injury, fibrosis and hepatocellular carcinoma. Nat
Rev Gastroenterol Hepatol. 8:108–118. 2011.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Pabst O, Hornef MW, Schaap FG, Cerovic V,
Clavel T and Bruns T: Gut-liver axis: Barriers and functional
circuits. Nat Rev Gastroenterol Hepatol. 20:447–461.
2023.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Hov JR and Karlsen TH: The microbiota and
the gut-liver axis in primary sclerosing cholangitis. Nat Rev
Gastroenterol Hepatol. 20:135–154. 2023.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Anand S and Mande SS: Host-microbiome
interactions: Gut-Liver axis and its connection with other organs.
NPJ Biofilms Microbiomes. 8(89)2022.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lynch SV and Pedersen O: The human
intestinal microbiome in health and disease. N Engl J Med.
375:2369–2379. 2016.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Lavelle A, Lennon G, Winter DC and
O'Connell PR: Colonic biogeography in health and ulcerative
colitis. Gut Microbes. 7:435–442. 2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Maslennikov R, Poluektova E, Zolnikova O,
Sedova A, Kurbatova A, Shulpekova Y, Dzhakhaya N, Kardasheva S,
Nadinskaia M, Bueverova E, et al: Gut microbiota and bacterial
translocation in the pathogenesis of liver fibrosis. Int J Mol Sci.
24(16502)2023.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Liu Y, Chen Z, Li C, Sun T, Luo X, Jiang
B, Liu M, Wang Q, Li T, Cao J, et al: Associations between changes
in the gut microbiota and liver cirrhosis: A systematic review and
meta-analysis. BMC Gastroenterol. 25(16)2025.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kang EJ, Cha MG, Kwon GH, Han SH, Yoon SJ,
Lee SK, Ahn ME, Won SM, Ahn EH and Suk KT: Akkermansia muciniphila
improve cognitive dysfunction by regulating BDNF and serotonin
pathway in gut-liver-brain axis. Microbiome. 12(181)2024.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sharma SP, Gupta H, Kwon GH, Lee SY, Song
SH, Kim JS, Park JH, Kim MJ, Yang DH, Park H, et al: Gut microbiome
and metabolome signatures in liver cirrhosis-related complications.
Clin Mol Hepatol. 30:845–862. 2024.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Hackstein CP, Assmus LM, Welz M, Klein S,
Schwandt T, Schultze J, Förster I, Gondorf F, Beyer M, Kroy D, et
al: Gut microbial translocation corrupts myeloid cell function to
control bacterial infection during liver cirrhosis. Gut.
66:507–518. 2017.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Qin N, Yang F, Li A, Prifti E, Chen Y,
Shao L, Guo J, Le Chatelier E, Yao J, Wu L, et al: Alterations of
the human gut microbiome in liver cirrhosis. Nature. 513:59–64.
2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Shashni B, Tajika Y, Ikeda Y, Nishikawa Y
and Nagasaki Y: Self-assembling polymer-based short chain fatty
acid prodrugs ameliorate non-alcoholic steatohepatitis and liver
fibrosis. Biomaterials. 295(122047)2023.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Mao T, Zhang C, Yang S, Bi Y, Li M and Yu
J: Semaglutide alters gut microbiota and improves NAFLD in db/db
mice. Biochem Biophys Res Commun. 710(149882)2024.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Spiljar M, Merkler D and Trajkovski M: The
immune system bridges the gut microbiota with systemic energy
homeostasis: Focus on TLRs, mucosal barrier, and SCFAs. Front
Immunol. 8(1353)2017.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Acharya C and Bajaj JS: Gut microbiota and
complications of liver disease. Gastroenterol Clin North Am.
46:155–169. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Jandl B, Dighe S, Baumgartner M,
Makristathis A, Gasche C and Muttenthaler M: Gastrointestinal
biofilms: Endoscopic detection, disease relevance, and therapeutic
strategies. Gastroenterology. 167:1098–1112.e5. 2024.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang J, He M, Yang M and An X: Gut
microbiota as a key regulator of intestinal mucosal immunity. Life
Sci. 345(122612)2024.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Kuo CH, Wu LL, Chen HP, Yu J and Wu CY:
Direct effects of alcohol on gut-epithelial barrier: Unraveling the
disruption of physical and chemical barrier of the gut-epithelial
barrier that compromises the host-microbiota interface upon alcohol
exposure. J Gastroenterol Hepatol. 39:1247–1255. 2024.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Jung Y, Witek RP, Syn WK, Choi SS,
Omenetti A, Premont R, Guy CD and Diehl AM: Signals from dying
hepatocytes trigger growth of liver progenitors. Gut. 59:655–665.
2010.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Seki E and Schwabe RF: Hepatic
inflammation and fibrosis: Functional links and key pathways.
Hepatology. 61:1066–1079. 2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Du YN, Tang XF, Xu L, Chen WD, Gao PJ and
Han WQ: SGK1-FoxO1 signaling pathway mediates Th17/Treg imbalance
and target organ inflammation in angiotensin II-induced
hypertension. Front Physiol. 9(1581)2018.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Muranski P and Restifo NP: Essentials of
Th17 cell commitment and plasticity. Blood. 121:2402–2414.
2013.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Liu R, Kang JD, Sartor RB, Sikaroodi M,
Fagan A, Gavis EA, Zhou H, Hylemon PB, Herzog JW, Li X, et al:
Neuroinflammation in murine cirrhosis is dependent on the gut
microbiome and is attenuated by fecal transplant. Hepatology.
71:611–626. 2020.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Zhao B, Jin Y, Shi M, Yu L, Li G, Cai W,
Lu Z and Wei C: Gut microbial dysbiosis is associated with
metabolism and immune factors in liver fibrosis mice. Int J Biol
Macromol. 258(129052)2024.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Santiago A, Sanchez E, Clark A, Pozuelo M,
Calvo M, Yañez F, Sarrabayrouse G, Perea L, Vidal S, Gallardo A, et
al: Sequential changes in the mesenteric lymph node microbiome and
immune response during cirrhosis induction in rats. mSystems.
4:e00278–18. 2019.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Durand F and Valla D: Assessment of the
prognosis of cirrhosis: Child-Pugh versus MELD. J Hepatol. 42
(Suppl 1):S100–S107. 2005.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Tan S, Chen X, Xu M, Huang X, Liu H, Jiang
J, Lu Y, Peng X and Wu B: PGE2/EP4 receptor
attenuated mucosal injury via β-arrestin1/Src/EGFR-mediated
proliferation in portal hypertensive gastropathy. Br J Pharmacol.
174:848–866. 2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Tan S, Li L, Chen T, Chen X, Tao L, Lin X,
Tao J, Huang X, Jiang J, Liu H and Wu B: β-Arrestin-1 protects
against endoplasmic reticulum stress/p53-upregulated modulator of
apoptosis-mediated apoptosis via repressing p-p65/inducible nitric
oxide synthase in portal hypertensive gastropathy. Free Radic Biol
Med. 87:69–83. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Tan S, Lu Y, Xu M, Huang X, Liu H, Jiang J
and Wu B: β-Arrestin1 enhances liver fibrosis through
autophagy-mediated Snail signaling. FASEB J. 33:2000–2016.
2019.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Xiao Y, Liu X, Xie K, Luo J, Zhang Y,
Huang X, Luo J and Tan S: Mitochondrial dysfunction induced by
HIF-1α under hypoxia contributes to the development of gastric
mucosal lesions. Clin Transl Med. 14(e1653)2024.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Wang R, Li B, Huang B, Li Y, Liu Q, Lyu Z,
Chen R, Qian Q, Liang X, Pu X, et al: Gut microbiota-derived
butyrate induces epigenetic and metabolic reprogramming in
myeloid-derived suppressor cells to alleviate primary biliary
cholangitis. Gastroenterology. 167:733–749.e3. 2024.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Solé C, Guilly S, Da Silva K, Llopis M,
Le-Chatelier E, Huelin P, Carol M, Moreira R, Fabrellas N, De Prada
G, et al: Alterations in gut microbiome in cirrhosis as assessed by
quantitative metagenomics: relationship with acute-on-chronic liver
failure and prognosis. Gastroenterology. 160:206–218.e13.
2021.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Shen Y, Wu SD, Chen Y, Li XY, Zhu Q,
Nakayama K, Zhang WQ, Weng CZ, Zhang J, Wang HK, et al: Alterations
in gut microbiome and metabolomics in chronic hepatitis B
infection-associated liver disease and their impact on peripheral
immune response. Gut Microbes. 15(2155018)2023.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Hui W, Yu D, Cao Z and Zhao X: Butyrate
inhibit collagen-induced arthritis via Treg/IL-10/Th17 axis. Int
Immunopharmacol. 68:226–233. 2019.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Gevers D, Kugathasan S, Denson LA,
Vazquez-Baeza Y, Van Treuren W, Ren B, Schwager E, Knights D, Song
SJ, Yassour M, et al: The treatment-naive microbiome in new-onset
Crohn's disease. Cell Host Microbe. 15:382–392. 2014.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Lepage P, Häsler R, Spehlmann ME, Rehman
A, Zvirbliene A, Begun A, Ott S, Kupcinskas L, Doré J, Raedler A
and Schreiber S: Twin study indicates loss of interaction between
microbiota and mucosa of patients with ulcerative colitis.
Gastroenterology. 141:227–236. 2011.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Ahn J, Sinha R, Pei Z, Dominianni C, Wu J,
Shi J, Goedert JJ, Hayes RB and Yang L: Human gut microbiome and
risk for colorectal cancer. J Natl Cancer Inst. 105:1907–1911.
2013.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chen Y, Yang F, Lu H, Wang B, Chen Y, Lei
D, Wang Y, Zhu B and Li L: Characterization of fecal microbial
communities in patients with liver cirrhosis. Hepatology.
54:562–572. 2011.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Sarangi AN, Goel A, Singh A, Sasi A and
Aggarwal R: Faecal bacterial microbiota in patients with cirrhosis
and the effect of lactulose administration. BMC Gastroenterol.
17(125)2017.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Qi P, Yang XX, Wang CK, Sang W, Zhang W
and Bai Y: Analysis of gut and circulating microbiota
characteristics in patients with liver cirrhosis and portal vein
thrombosis. Front Microbiol. 16(1597145)2025.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Jian Y, Zhang D, Liu M, Wang Y and Xu ZX:
The impact of gut microbiota on radiation-induced enteritis. Front
Cell Infect Microbiol. 11(586392)2021.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Wang Y, Wang Y, Ma J, Li Y, Cao L, Zhu T,
Hu H and Liu H: YuPingFengSan ameliorates LPS-induced acute lung
injury and gut barrier dysfunction in mice. J Ethnopharmacol.
312(116452)2023.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Jiang Y, Song J, Xu Y, Liu C, Qian W, Bai
T and Hou X: Piezo1 regulates intestinal epithelial function by
affecting the tight junction protein claudin-1 via the ROCK
pathway. Life Sci. 275(119254)2021.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Kumar A, Priyamvada S, Ge Y, Jayawardena
D, Singhal M, Anbazhagan AN, Chatterjee I, Dayal A, Patel M, Zadeh
K, et al: A novel role of SLC26A3 in the maintenance of intestinal
epithelial barrier integrity. Gastroenterology. 160:1240–1255.e3.
2021.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Jadhav K and Cohen TS: Can you trust your
gut? Implicating a disrupted intestinal microbiome in the
progression of NAFLD/NASH. Front Endocrinol (Lausanne).
11(592157)2020.PubMed/NCBI View Article : Google Scholar
|
